Orange Book product · Generic (ANDA)
CEFDINIR
CEFDINIR
At a glance
Jan 07, 2008
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 07, 2008
18 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFDINIR
Strength
300MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 065434
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFDINIR
- 1997OMNICEFBrand (NDA)
NDA 050739 · ABBVIE
- 1997OMNICEFBrand (NDA)
NDA 050749 · ABBVIE
- 2021CEFDINIRGeneric (ANDA)
ANDA 210220 · ALKEM LABS LTD
- 2021CEFDINIRGeneric (ANDA)
ANDA 210534 · ALKEM LABS LTD
- 2007CEFDINIRGeneric (ANDA)
ANDA 065473 · AUROBINDO PHARMA
- 2007CEFDINIRGeneric (ANDA)
ANDA 065418 · ANDA REPOSITORY
- 2007CEFDINIRGeneric (ANDA)
ANDA 065429 · ANDA REPOSITORY
- 2007CEFDINIRGeneric (ANDA)
ANDA 065368 · TEVA PHARMS
- 2007CEFDINIRGeneric (ANDA)
ANDA 065332 · TEVA PHARMS
- 2007CEFDINIRGeneric (ANDA)
ANDA 065330 · CHARTWELL RX
- 2007CEFDINIRGeneric (ANDA)
ANDA 065337 · CHARTWELL RX
- 2006CEFDINIRGeneric (ANDA)
ANDA 065259 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
